Ojha, Juhi
Dyagil, Iryna
Finch, Stuart C.
Reiss, Robert F.
de Smith, Adam J.
Gonseth, Semira
Zhou, Mi
Hansen, Helen M.
Sherborne, Amy L.
Nakamura, Jean
Bracci, Paige M.
Gudzenko, Nataliya
Hatch, Maureen
Babkina, Nataliya
Little, Mark P.
Chumak, Vadim V.
Walsh, Kyle M.
Bazyka, Dimitry
Wiemels, Joseph L.
Zablotska, Lydia B. http://orcid.org/0000-0002-0778-1108
Funding for this research was provided by:
National Cancer Institute (NO1-CP-2117, 5K07CA132918, 5R03CA188614, 5R21CA115043-2)
National Human Genome Research Institute (5U54HG003067)
The Blavatnik Family Foundation
Howard Hughes Medical Institute
Damon Runyon Cancer Research Foundation (CI-38-07)
Article History
Received: 6 December 2017
Accepted: 20 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The protocol for the study was approved by the institutional review boards of the University of California, San Francisco, School of Medicine (San Francisco, CA, USA) and NRCRM (Kyiv, Ukraine). All participants signed written consent forms.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.